Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Devgen/Sumitomo Chemical extend research deal

Belgian biotechnology company Devgen (Ghent) has renewed its research and development collaboration with Sumitomo Chemical for a further three-year term. Devgen will receive funding for its research activities and be eligible for royalties. The two companies have been working together since 2001 ( Agrow No 425, p 2). They agreed a two-year extension in 2006 ( Agrow No 499, p 5). Sumitomo believes that the renewal of the deal will enhance the probability of finding a unique and safer active ingredient. In 2007, Devgen entered into a five-year R&D and technology exchange agreement with Monsanto ( Agrow No 514, p 2) before Monsanto acquired a 5.9% stake in it later that year ( Agrow No 528, p 5). Towards the end of last year, Devgen closed its pharmaceutical division to fully focus on the development of its agricultural business ( Agrow No 556, p 1).


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts